AJANTA PHARMA LTD. (AJANTPHARM)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 1,014.58 945.18 1,085.29 926.07 1,077.27 1,128.91 1,101.92 1,013.94 1,208.56 1,220.24 1,206.59 1,210.53
YOY Revenue Growth % 32.52% 12.89% 24.05% 9.1% 6.18% 19.44% 1.53% 9.49% 12.19% 8.09% 9.5% 19.39%
Other Income 31.46 52.16 13.73 33.68 28.37 40.34 33.23 17.93 40.63 75.03 25.76 62.98
Total Income 1,046.04 997.34 1,099.02 959.75 1,105.64 1,169.25 1,135.15 1,031.87 1,249.19 1,295.27 1,232.35 1,273.51
Total Expenses + 663.82 654.89 689.46 718.08 741.91 765.78 721.36 803.72 920.20 973.30 909.89 1,015.90
Cost of Materials Consumed 217.81 223.55 239.04 259.03 238.41 207.09 210.14 190.96 207.08 217.60 235.07 256.77
Employee Benefit Expense 196.30 205.48 216.41 215.97 265.68 241.65 245.71 257.86 280.96 293.44 306.16 313.49
Other Expenses 249.71 225.86 234.01 243.08 237.82 317.04 265.51 274.03 334.75 343.33 304.75 393.79
Operating Profit 350.76 290.29 395.83 207.99 335.36 363.13 380.56 210.22 288.36 246.94 296.70 194.63
OPM % 34.6% 30.7% 36.5% 22.5% 31.1% 32.2% 34.5% 20.7% 23.9% 20.2% 24.6% 16.1%
Profit Before Tax + 275.37 290.50 305.14 225.94 310.56 309.20 332.15 228.15 328.99 321.97 322.46 257.61
Tax Expense 63.33 78.14 84.99 63.25 74.53 74.22 79.70 34.72 74.02 72.44 77.42 60.33
Tax % 23% 26.9% 27.9% 28% 24% 24% 24% 15.2% 22.5% 22.5% 24% 23.4%
Profit After Tax 212.04 212.36 220.15 162.69 236.03 234.98 252.45 193.43 254.97 249.53 245.04 197.28
EPS (Basic) 16.84 16.87 17.48 12.92 18.77 18.75 20.16 15.46 20.41 19.98 19.61 15.79

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 4,322.04 3,971.12 3,411.27 3,140.64 2,718.59 2,196.42 1,772.62
YOY Revenue Growth % 8.84% 16.41% 8.62% 15.52% 23.77% 23.91% -
Other Income 119.87 116.48 132.75 139.73 103.57 184.20 102.15
Total Income 4,441.91 4,087.60 3,544.02 3,280.37 2,822.16 2,380.62 1,874.77
Total Expenses + 3,261.85 2,711.70 2,584.94 2,190.23 1,775.69 1,555.89 1,288.00
Cost of Materials Consumed 846.60 939.43 878.36 773.04 704.09 556.22 388.71
Employee Benefit Expense 1,010.90 834.16 720.41 585.87 498.11 437.82 389.37
Other Expenses 1,094.40 938.11 986.17 831.32 573.49 561.85 509.92
Operating Profit 1,060.19 1,259.42 826.33 950.41 942.90 640.53 484.62
OPM % 24.5% 31.7% 24.2% 30.3% 34.7% 29.2% 27.3%
Profit Before Exceptional 1,180.06 1,096.95 699.85 900.54 902.09 616.59 513.05
Exceptional Items 0.00 0.00 0.00 0.00 0.00 -3.92 0.00
Profit Before Tax + 1,180.06 1,096.95 699.85 900.54 902.09 612.67 513.05
Tax Expense 263.17 289.71 141.13 180.68 226.45 171.54 121.29
Tax % 22.3% 26.4% 20.2% 20.1% 25.1% 28% 23.6%
Profit After Tax 916.89 807.24 558.72 719.86 675.64 441.13 391.76
EPS (Basic) 73.28 64.11 43.61 83.28 77.59 50.55 44.51

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 1,978.19 1,775.77 1,752.77 0.00 0.00 0.00 0.00
Property, Plant & Equipment 1,621.61 1,376.86 1,399.84 0.00 0.00 0.00 0.00
Capital Work in Progress 176.27 256.45 209.47 0.00 0.00 0.00 0.00
Non-Current Investments 43.13 37.09 42.99 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 120.35 88.03 84.17 0.00 0.00 0.00 0.00
Current Assets + 2,567.21 2,432.82 2,544.10 0.00 0.00 0.00 0.00
Inventories 739.29 677.79 683.77 0.00 0.00 0.00 0.00
Trade Receivables 1,225.81 1,207.67 977.63 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 48.60 61.78 268.85 0.00 0.00 0.00 0.00
Current Investments 438.71 330.05 510.27 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 25.07 25.27 25.27 0.00 0.00 0.00 0.00
Other Equity 3,600.24 3,388.30 3,221.18 0.00 0.00 0.00 0.00
Non-Current Liabilities 218.22 174.17 150.50 0.00 0.00 0.00 0.00
Current Liabilities 710.72 629.19 907.84 0.00 0.00 0.00 0.00
Total Liabilities 928.94 803.87 1,058.34 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 1,053.80 735.35 736.29 542.36 0.00 0.00 0.00
Cash from Investing Activities -349.60 105.02 -501.31 -66.04 0.00 0.00 0.00
Cash from Financing Activities -715.71 -1,047.70 -105.12 -457.32 0.00 0.00 0.00
Net Increase/Decrease in Cash -13.18 -207.07 129.02 19.95 0.00 0.00 0.00